BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9816236)

  • 1. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients.
    Yamamoto Y; Toi M; Kondo S; Matsumoto T; Suzuki H; Kitamura M; Tsuruta K; Taniguchi T; Okamoto A; Mori T; Yoshida M; Ikeda T; Tominaga T
    Clin Cancer Res; 1996 May; 2(5):821-6. PubMed ID: 9816236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
    Adams J; Carder PJ; Downey S; Forbes MA; MacLennan K; Allgar V; Kaufman S; Hallam S; Bicknell R; Walker JJ; Cairnduff F; Selby PJ; Perren TJ; Lansdown M; Banks RE
    Cancer Res; 2000 Jun; 60(11):2898-905. PubMed ID: 10850435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P; Orpana A; Joensuu H
    Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ; Li JR; Li ZB
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
    Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
    J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer.
    Eroğlu A; Demirci S; Ayyildiz A; Kocaoğlu H; Akbulut H; Akgül H; Elhan HA
    Br J Cancer; 1999 Jul; 80(10):1630-4. PubMed ID: 10408410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment.
    Wu Y; Saldana L; Chillar R; Vadgama JV
    Int J Oncol; 2002 Mar; 20(3):509-16. PubMed ID: 11836562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
    Salven P; Mänpää H; Orpana A; Alitalo K; Joensuu H
    Clin Cancer Res; 1997 May; 3(5):647-51. PubMed ID: 9815732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
    Feldman AL; Tamarkin L; Paciotti GF; Simpson BW; Linehan WM; Yang JC; Fogler WE; Turner EM; Alexander HR; Libutti SK
    Clin Cancer Res; 2000 Dec; 6(12):4628-34. PubMed ID: 11156212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
    Broll R; Erdmann H; Duchrow M; Oevermann E; Schwandner O; Markert U; Bruch HP; Windhövel U
    Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer.
    Takigawa N; Segawa Y; Fujimoto N; Hotta K; Eguchi K
    Anticancer Res; 1998; 18(2B):1251-4. PubMed ID: 9615796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M; Ohta Y
    Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?
    Lee JK; Hong YJ; Han CJ; Hwang DY; Hong SI
    Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma.
    Balsari A; Maier JA; Colnaghi MI; Ménard S
    Lab Invest; 1999 Jul; 79(7):897-902. PubMed ID: 10418830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
    Holzer G; Obermair A; Koschat M; Preyer O; Kotz R; Trieb K
    Med Pediatr Oncol; 2001 Jun; 36(6):601-4. PubMed ID: 11344490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
    Lantzsch T; Hefler L; Krause U; Kehl A; Goepel C; Koelbl H; Dunst J; Lampe D
    Anticancer Res; 2002; 22(3):1925-8. PubMed ID: 12168895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.